The risk of community-acquired pneumonia among 9803 patients with coeliac disease compared to the general population: a cohort study

Zingone, Fabiana; Abdul Sultan, Alyshah; Crooks, Colin J.; Tata, Laila J.; Ciacci, Carolina; West, Joe

doi:10.1111/apt.13652

All Outputs (4)

Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study (2016)
Journal Article

Objective To examine the risk of community acquired pneumonia before and after prescription of proton pump inhibitor (PPI) and assess whether unmeasured confounding explains this association. Design Cohort study and self controlled case series. S... Read More about Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.

The use of a bayesian hierarchy to develop and validate a co-morbidity score to predict mortality for linked primary and secondary care data from the NHS in England (2016)
Journal Article

Background: We have assessed whether the linkage between routine primary and secondary care records provided an opportunity to develop an improved population based co-morbidity score with the combined information on co-morbidities from both health ca... Read More about The use of a bayesian hierarchy to develop and validate a co-morbidity score to predict mortality for linked primary and secondary care data from the NHS in England.

Proton pump inhibitor prescribing patterns in the UK: a primary care database study (2016)
Journal Article

Purpose: To determine the prevalence and pattern of proton pump inhibitor (PPI) prescription and the practices employed to reduce PPI use in the UK general population. Methods: The UK's Clinical Practice Research Database was used to identify indi... Read More about Proton pump inhibitor prescribing patterns in the UK: a primary care database study.

The risk of community-acquired pneumonia among 9803 patients with coeliac disease compared to the general population: a cohort study (2016)
Journal Article

Background: Patients with coeliac disease are considered as individuals for whom pneumococcal vaccination is advocated. Aim: To quantify the risk of community-acquired pneumonia among patients with coeliac disease, assessing whether vaccination ag... Read More about The risk of community-acquired pneumonia among 9803 patients with coeliac disease compared to the general population: a cohort study.